H. Lee Moffitt Cancer Center & Research Institute

January / February 1998

Vol 5, No 1 CME Pretest

In this issue, the topic of T-cell lymphoid malignancies is addressed. First, answer the pretest questions below. After reading the articles, proceed with answering the CME posttest questions.


This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicans can earn up to 4 credit hours of Category 1 for the Physican's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

  • describe the clinical features and management approaches to selected T-cell leukemias and lymphomas;
  • appreciate the current status of systemic management of advanced soft-tissue sarcomas; and
  • be aware of the presentation and management of nocardiosis in patients with cancer.

This program was planned in accordance with ACCME Essentials.
Release Date: January 1, 1998 Expiration Date: January 1, 1999


Pretest


1. What level of peripheral white blood cell count is most common in patients who present with T-cell prolymphocytic leukemia (T-PLL)?
a. 1 to 2 X 109/L
b. 15 to 20 X 109/L
c. 50 to 75 X 109/L
d. >100 X 109/L
2. Which component of the skin is least often involved by T-PLL?
a. epidermis
b. dermis
c. dermal lymphatics
d. skin appendages
3. What is the median age in years of patients affected by T-PLL?
a. 3
b. 18
c. 65
d. 85



© Copyright 1996 - 2008 H. Lee Moffitt Cancer Center & Research Institute